Katalin Fábián

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Lívia Rojkó, Lilla Reiniger, Vanda Téglási et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 99 citations · Full text

Medicine, Cancer Biology, Oncology +16

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

Zoltán Lohinai, Mir Alireza Hoda, Katalin Fábián et al. · Journal of Thoracic Oncology · 2015 · 82 citations · Full text

Medicine, Genetics, Oncology +15

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Zoltán Lohinai, Thomas Klikovits, Judit Moldvay et al. · Scientific Reports · 2017 · 79 citations · Full text

Medicine, Oncology, Metastasis +11

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy

Mihály Cserepes, Gyula Ostoros, Zoltán Lohinai et al. · European Journal of Cancer · 2014 · 72 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers

Yoann Aldon, Paul F. McKay, Joel D. Allen et al. · Cell Reports · 2018 · 59 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +9